ReviewTurkish journal of haematology : official journal of Turkish Society of Haematology2025
Patient Blood Management in Pediatric Patients: Current Strategies and Future Perspectives
Review in Turkish journal of haematology : official journal of Turkish Society of Haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patient blood management (PBM) is an evidence-based, multidisciplinary approach aimed at optimizing the care of patients who might require transfusion. While PBM has been widely adopted in adult practice, its application in pediatric settings remains limited and inconsistent despite the unique physiological and clinical challenges of this population. This review highlights the current strategies and future directions of PBM in pediatric patients. Key elements of pediatric PBM include the preservation of red cell mass and the management of preoperative anemia, strategies to minimize iatrogenic and surgical blood loss, approaches to enhance patients’ physiological tolerance to anemia, and optimization of transfusion practices. Recent studies support the use of restrictive transfusion thresholds for critically ill children, neonates, and specific high-risk groups such as those with congenital heart disease, demonstrating no added benefit of liberal transfusion practices. Looking ahead, advances in precision medicine, artificial intelligence, and non-invasive monitoring technologies are expected to further individualize transfusion practices and strengthen PBM implementation in pediatric care. However, high-quality pediatric-specific research remains essential to establish standardized protocols and ensure safe, effective, and patient-centered blood management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.